Skip Navigation

QJM 2007 100(9):597-598; doi:10.1093/qjmed/hcm070
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Launer, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Launer, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Personal risk

John Launer

The first 10% of the full text of this article appears below.

How do you make the right decision about preventive treatment when n = 1 and you happen to be the ‘n ’ concerned? I recently had to do this for myself, and it has made me reflect on how I approach this with my patients, too.

My own dilemma related to taking warfarin. Many years ago I had a series of unexplained pulmonary micro-emboli. I was screened for all the known genetic factors, but no particular cause was found. However, my mother died suddenly in her early sixties from a massive pulmonary embolus, so a genetic influence seemed likely. My haematologist suggested that I should take long-term warfarin, . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?